<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药明康德 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-05T11:19:44+08:00</updated>
  <subtitle>全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台，帮助任何人、任何公司更快、更好地研发新医药产品，探索无限可能</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>《自然》：用血检确定新冠疫苗的保护效力？科学家完成动物概念验证</title>
    <updated>2020-12-05T07:43:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/8mIsnaGXpMEdzemdQl-mLw</id>
    <link href="https://mp.weixin.qq.com/s/8mIsnaGXpMEdzemdQl-mLw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>罕见病专栏 | 一周罕闻药事（11.27-12.4）</title>
    <updated>2020-12-05T07:43:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/MhDENzvmdTeHFZDm5LTZZQ</id>
    <link href="https://mp.weixin.qq.com/s/MhDENzvmdTeHFZDm5LTZZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | “一周一针”索马鲁肽控制体重，诺和诺德使用优先审评券递交监管申请</title>
    <updated>2020-12-05T07:43:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/YKios_T9-B6NHmIoG3l23Q</id>
    <link href="https://mp.weixin.qq.com/s/YKios_T9-B6NHmIoG3l23Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 ASH双抗篇| 再生元、罗氏、强生、辉瑞等公司双特异性抗体疗法将集体亮相！</title>
    <updated>2020-12-05T07:43:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/9ySwuQduhQtGhVo9I5Zfmw</id>
    <link href="https://mp.weixin.qq.com/s/9ySwuQduhQtGhVo9I5Zfmw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | FDA批准口服创新疗法，预防遗传性血管水肿发作</title>
    <updated>2020-12-05T07:43:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/SATIpb4UDgShue6XhEx60w</id>
    <link href="https://mp.weixin.qq.com/s/SATIpb4UDgShue6XhEx60w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>致敬时代，感恩有你——写在药明康德成立20周年</title>
    <updated>2020-12-04T07:59:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/26gVP5swkcRjIcUtS7slHg</id>
    <link href="https://mp.weixin.qq.com/s/26gVP5swkcRjIcUtS7slHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新20年：那些被人类改变了的疾病 | 致敬时代，感恩有你</title>
    <updated>2020-12-04T07:59:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/9J3E7rBBhjhDXBwHt5-Y2g</id>
    <link href="https://mp.weixin.qq.com/s/9J3E7rBBhjhDXBwHt5-Y2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新20年：造福全球病患的时代 | 致敬时代，感恩有你</title>
    <updated>2020-12-04T07:59:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/sDyNZJXx_n6ZBXzvl9Jg4Q</id>
    <link href="https://mp.weixin.qq.com/s/sDyNZJXx_n6ZBXzvl9Jg4Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新20年：生命科学的九个突破 | 致敬时代，感恩有你</title>
    <updated>2020-12-04T07:59:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/e06d7lxXrUktxbzqScQFQg</id>
    <link href="https://mp.weixin.qq.com/s/e06d7lxXrUktxbzqScQFQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NEJM：接种90天后中和抗体水平仍高于康复患者，Moderna新冠疫苗持久性最新结果出炉</title>
    <updated>2020-12-04T07:59:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/VVWNZOCSFR9NucNtCZzgPQ</id>
    <link href="https://mp.weixin.qq.com/s/VVWNZOCSFR9NucNtCZzgPQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 杨森递交EGFR/MET双特异性抗体监管申请，治疗特定非小细胞肺癌患者</title>
    <updated>2020-12-04T07:59:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/qE1EbSdPTAEUffgXS9xREw</id>
    <link href="https://mp.weixin.qq.com/s/qE1EbSdPTAEUffgXS9xREw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药明康德荣膺弗若斯特沙利文“2020全球客户价值领导力奖” | Bilingual News</title>
    <updated>2020-12-03T07:37:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/6Cg2-sBEw8yX9ViEDULGFg</id>
    <link href="https://mp.weixin.qq.com/s/6Cg2-sBEw8yX9ViEDULGFg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 辉瑞/BioNTech新冠疫苗在英国首先获紧急使用授权</title>
    <updated>2020-12-03T07:37:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/MQjLJeIA46q0ww4XB52bvg</id>
    <link href="https://mp.weixin.qq.com/s/MQjLJeIA46q0ww4XB52bvg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 10亿美元开发创新蛋白降解疗法，艾伯维达成研发合作</title>
    <updated>2020-12-03T07:37:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/TFiTR2MwzsX_1zCftHPPeA</id>
    <link href="https://mp.weixin.qq.com/s/TFiTR2MwzsX_1zCftHPPeA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | FDA批准首个抗IgE抗体鼻息肉疗法</title>
    <updated>2020-12-03T07:37:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/ce2dFQLRe-hoqTNyrSMblg</id>
    <link href="https://mp.weixin.qq.com/s/ce2dFQLRe-hoqTNyrSMblg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首次看清，新冠病毒如何入侵人类大脑！《自然》子刊展示高清图像</title>
    <updated>2020-12-03T07:37:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/lkmHs-4wUJmoSd1YCWB_7Q</id>
    <link href="https://mp.weixin.qq.com/s/lkmHs-4wUJmoSd1YCWB_7Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国常见，槟榔致癌成分首次确认！国际癌症研究机构发布评估结果</title>
    <updated>2020-12-03T07:37:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/vVDwZWXJ71_EgJdHoJ5vNA</id>
    <link href="https://mp.weixin.qq.com/s/vVDwZWXJ71_EgJdHoJ5vNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药明康德宣布与ViGeneron达成新一代眼科基因疗法产品生产合作 | Bilingual News</title>
    <updated>2020-12-02T07:43:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/WA0NFV-g73rkdpBoP_1J8w</id>
    <link href="https://mp.weixin.qq.com/s/WA0NFV-g73rkdpBoP_1J8w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | FDA批准首款PSMA靶向PET成像药物，用于前列腺癌患者诊疗</title>
    <updated>2020-12-02T07:43:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/Z7GWgiqIbD_tU93d6ICnLw</id>
    <link href="https://mp.weixin.qq.com/s/Z7GWgiqIbD_tU93d6ICnLw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 口服FGFR抑制剂获FDA优先审评资格，治疗胆管癌</title>
    <updated>2020-12-02T07:43:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/MGUnW8xUBPX7f53TTkphuw</id>
    <link href="https://mp.weixin.qq.com/s/MGUnW8xUBPX7f53TTkphuw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>